Proposed Data Collection Submitted for Public Comment and Recommendations, 52575-52577 [2022-18443]

Download as PDF 52575 Federal Register / Vol. 87, No. 165 / Friday, August 26, 2022 / Notices ESTIMATED ANNUALIZED BURDEN HOURS—Continued Number of respondents Form number & name 57.308 Hemovigilance Adverse Reaction—Allergic Transfusion Reaction ..... 57.309 Hemovigilance Adverse Reaction—Delayed Hemolytic Transfusion Reaction ....................................................................................................... 57.310 Hemovigilance Adverse Reaction—Delayed Serologic Transfusion Reaction ....................................................................................................... 57.311 Hemovigilance Adverse Reaction—Febrile Non-hemolytic Transfusion Reaction ............................................................................................ 57.312 Hemovigilance Adverse Reaction—Hypotensive Transfusion Reaction ................................................................................................................ 57.313 Hemovigilance Adverse Reaction—Infection ...................................... 57.314 Hemovigilance Adverse Reaction—Post Transfusion Purpura ........... 57.315 Hemovigilance Adverse Reaction—Transfusion Associated Dyspnea 57.316 Hemovigilance Adverse Reaction—Transfusion Associated Graft vs. Host Disease ................................................................................................ 57.317 Hemovigilance Adverse Reaction—Transfusion Related Acute Lung Injury ............................................................................................................. 57.318 Hemovigilance Adverse Reaction—Transfusion Associated Circulatory Overload ......................................................................................... 57.319 Hemovigilance Adverse Reaction—Unknown Transfusion Reaction .. 57.320 Hemovigilance Adverse Reaction—Other Transfusion Reaction ........ 57.400 Outpatient Procedure Component—Annual Facility Survey ............... 57.401 Outpatient Procedure Component—Monthly Reporting Plan ............. 57.402 Outpatient Procedure Component Same Day Outcome Measures .... 57.403 Outpatient Procedure Component—Monthly Denominators for Same Day Outcome Measures .............................................................................. 57.404 Outpatient Procedure Component—SSI Denominator ........................ 57.405 Outpatient Procedure Component—Surgical Site (SSI) Event ........... 57.500 Outpatient Dialysis Center Practices Survey ...................................... 57.501 Dialysis Monthly Reporting Plan .......................................................... 57.502 Dialysis Event ...................................................................................... 57.503 Denominator for Outpatient Dialysis .................................................... 57.504 Prevention Process Measures Monthly Monitoring for Dialysis .......... 57.505 Dialysis Patient Influenza Vaccination ................................................. 57.506 Dialysis Patient Influenza Vaccination Denominator ........................... 57.507 Home Dialysis Center Practices Survey ............................................. Weekly Healthcare Personnel Influenza Vaccination Cumulative Summary for Non-Long-Term Care Facilities ............................................................... Weekly Healthcare Personnel Influenza Vaccination Cumulative Summary for Long-Term Care Facilities ...................................................................... Weekly Resident Influenza Vaccination Cumulative Summary for Long-Term Care Facilities .............................................................................................. Annual Healthcare Personnel Influenza Vaccination Summary ...................... Total .......................................................................................................... Jeffrey M. Zirger, Lead, Information Collection Review Office, Office of Scientific Integrity, Office of Science, Centers for Disease Control and Prevention. [FR Doc. 2022–18442 Filed 8–25–22; 8:45 am] BILLING CODE 4163–18–P 20/60 667 500 1 20/60 167 500 2 20/60 333 500 4 20/60 667 500 500 500 500 1 1 1 1 20/60 20/60 20/60 20/60 167 167 167 167 500 1 20/60 167 500 1 20/60 167 500 500 500 700 700 200 2 1 1 1 12 1 20/60 20/60 20/60 10/60 15/60 40/60 333 167 167 117 2,100 133 200 700 700 7,400 7,400 7,400 7,400 1,730 615 615 450 400 100 5 1 12 30 24 12 50 5 1 40/60 40/60 40/60 125/60 5/60 27/60 10/60 75/60 10/60 10/60 36/60 53,333 46,667 2,333 15,417 7,400 99,900 29,600 25,950 5,125 3075 270 125 52 60/60 6,500 1,200 52 60/60 62,400 2,500 5,000 52 1 60/60 120/60 130,000 10,000 ........................ ........................ ........................ 1,614,345 DEPARTMENT OF HEALTH AND HUMAN SERVICES Centers for Disease Control and Prevention [60Day–22–1166; Docket No. CDC–2022– 0100] Centers for Disease Control and Prevention (CDC), Department of Health and Human Services (HHS). ACTION: Notice with comment period. lotter on DSK11XQN23PROD with NOTICES1 The Centers for Disease Control and Prevention (CDC), as part of its continuing effort to reduce public burden and maximize the utility of SUMMARY: Jkt 256001 PO 00000 Frm 00076 Fmt 4703 Total burden (in hours) 4 AGENCY: 16:59 Aug 25, 2022 Avg. burden per response (in hours) 500 Proposed Data Collection Submitted for Public Comment and Recommendations VerDate Sep<11>2014 Number of responses per respondent Sfmt 4703 government information, invites the general public and other federal agencies the opportunity to comment on a continuing information collection, as required by the Paperwork Reduction Act of 1995. This notice invites comment on a proposed information collection project titled Poison Center Collaborations for Public Health Emergencies. This proposed collection will allow CDC to quickly characterize potential exposures identified through the National Poison Data System (NPDS), help determine potential risk factors, identify illnesses related to the public health emergency, and improve the public health response to the incident. E:\FR\FM\26AUN1.SGM 26AUN1 52576 Federal Register / Vol. 87, No. 165 / Friday, August 26, 2022 / Notices CDC must receive written comments on or before October 25, 2022. DATES: You may submit comments, identified by Docket No. CDC–2022– 0100 by either of the following methods: • Federal eRulemaking Portal: www.regulations.gov. Follow the instructions for submitting comments. • Mail: Jeffrey M. Zirger, Information Collection Review Office, Centers for Disease Control and Prevention, 1600 Clifton Road NE, MS H21–8, Atlanta, Georgia 30329. Instructions: All submissions received must include the agency name and Docket Number. CDC will post, without change, all relevant comments to www.regulations.gov. Please note: Submit all comments through the Federal eRulemaking portal (www.regulations.gov) or by U.S. mail to the address listed above. FOR FURTHER INFORMATION CONTACT: To request more information on the proposed project or to obtain a copy of the information collection plan and instruments, contact Jeffrey M. Zirger, Information Collection Review Office, Centers for Disease Control and Prevention, 1600 Clifton Road NE, MS H21–8, Atlanta, Georgia 30329; Telephone: 404–639–7570; Email: omb@ cdc.gov. SUPPLEMENTARY INFORMATION: Under the Paperwork Reduction Act of 1995 (PRA) (44 U.S.C. 3501–3520), federal agencies must obtain approval from the Office of Management and Budget (OMB) for each collection of information they conduct or sponsor. In addition, the PRA also requires federal agencies to provide a 60-day notice in the Federal Register concerning each proposed collection of information, including each new proposed collection, each proposed extension of existing collection of information, and each reinstatement of previously approved information collection before submitting the collection to the OMB for approval. To comply with this requirement, we are publishing this notice of a proposed data collection as described below. The OMB is particularly interested in comments that will help: 1. Evaluate whether the proposed collection of information is necessary for the proper performance of the functions of the agency, including whether the information will have practical utility; 2. Evaluate the accuracy of the agency’s estimate of the burden of the proposed collection of information, including the validity of the methodology and assumptions used; lotter on DSK11XQN23PROD with NOTICES1 ADDRESSES: VerDate Sep<11>2014 16:59 Aug 25, 2022 Jkt 256001 3. Enhance the quality, utility, and clarity of the information to be collected; 4. Minimize the burden of the collection of information on those who are to respond, including through the use of appropriate automated, electronic, mechanical, or other technological collection techniques or other forms of information technology, e.g., permitting electronic submissions of responses; and 5. Assess information collection costs. Proposed Project Poison Center Collaborations for Public Health Emergencies (PCCPHE) (OMB Control No. 0920–1166, Exp. 04/ 30/2023)—Revision—National Center for Environmental Health (NCEH), Centers for Disease Control and Prevention (CDC). Background and Brief Description The Centers for Disease Control and Prevention (CDC) is requesting a threeyear Paperwork Reduction Act (PRA) Revision of the Generic Information Collection Request (Generic ICR) titled Poison Center Collaborations for Public Health Emergencies (PCCPHE) (OMB Control No. 0920–1166; Expiration date 04/30/2023). CDC’s key partner is America’s Poison Centers TM, formerly known as the American Association of Poison Control Centers (AAPCC). America’s Poison Centers TM is a national network of 55 poison centers working to prevent and treat poison exposures. America’s Poison Centers TM manages its existing surveillance system called the National Poison Data System (NPDS) and provides CDC access to monitor this system under a cooperative agreement and a data license agreement. When a public health emergency of interest emerges in NPDS, the CDC and America’s Poison Centers TM hold a meeting to mutually decide whether the incident needs further investigation. For a public health emergency to be selected for call-back, adverse health effects must have occurred, and a response is needed to prevent further morbidity and mortality. The event must meet the following criteria: (1) the event is a public health emergency causing adverse health effects; (2) timely data are urgently needed to inform rapid public health action to prevent or reduce injury, disease, or death; (3) the event is characterized by a natural or man-made disaster, contaminated food or water, a new or existing consumer product, or an emerging public health threat; (4) the event has resulted in calls to a poison center, and the poison center agrees to conduct the call-back data PO 00000 Frm 00077 Fmt 4703 Sfmt 4703 collection; (5) the event is domestic; and (6) data collection will be completed in 60 days or less. The purpose of this Generic ICR is to create a timely mechanism to allow poison centers, supported by CDC, to follow-up with callers during select public health emergencies on exposure and health. These PCCPHE Generic information collections (GenICs) will obtain information on sources of exposure, scenario of exposure, health seeking behaviors following exposure, and awareness of health communication messaging. These additional data can help CDC identify interventions to improve health messaging meant to reduce exposure; improve disaster and emergency response; and prevent future events for the specific area or incident of interest. Trained poison center staff will conduct the call-back telephone survey or will facilitate the call-back web survey, after administering consent. Respondents will include individuals who call poison centers about exposures related to the select public health emergencies. These respondents include adults, 18 years and older; adolescents, 15 to less than 18 years; and parents or guardians on behalf of their children less than 15 years of age. In 2019, a PCCPHE GenIC, titled ‘‘Risk Factors for Harmful Algal Blooms (HABs),’’ was conducted to identify sources of and risk factors for HAB exposures. New information gained about HAB exposures were used improve HAB incident response, communication, and outreach at the state and national level. During the past three-year approval period, no PCCPHE GenICs were conducted; however, two NPDS-related follow-up studies were implemented using the Secretary’s Public Health Emergency PRA Waiver for COVID–19. During a non-pandemic situation, these two studies would have used this Generic ICR. These studies assessed unintentional exposures associated with cleaning products (e.g., bleach, hand sanitizers) in home settings to determine knowledge, attitudes, and practices regarding cleaning behaviors and help guide public health messaging. Based on CDC’s past experience, the following revisions affecting public burden are proposed. CDC plans to increase the annual number of public health emergencies of interest from two to three per year. CDC will reduce the estimated time per response from 40 minutes to 10 minutes. CDC plans to add web surveys as a second secure mode of collection to the currently approved telephone surveys. CDC will also increase the annual number of E:\FR\FM\26AUN1.SGM 26AUN1 52577 Federal Register / Vol. 87, No. 165 / Friday, August 26, 2022 / Notices respondents from 150 to 500 per callback investigation. Based on these revisions, the total number of annual respondents requested is 1,500, which is an increase of 1,200 over the 300 respondents previously approved. The annual time burden requested is 250 hours, which is an increase of 50 hours over the 200 hours previously approved. There is no cost to the respondents other than their time. ESTIMATED ANNUALIZED BURDEN HOURS Average burden per response (in hours) Total burden (in hours) Form name Adult Poison Center Callers ............. Adolescent Poison Center Callers .... Parent or Guardian Poison Center Callers. Call-back Questionnaire for Self ...... Call-back Questionnaire for Self ...... Call-back Questionnaire for Proxy ... 1,200 150 150 1 1 1 10/60 10/60 10/60 200 25 25 Total ........................................... ........................................................... ........................ ........................ ........................ 250 Jeffrey M. Zirger, Lead, Information Collection Review Office, Office of Scientific Integrity, Office of Science, Centers for Disease Control and Prevention. [FR Doc. 2022–18443 Filed 8–25–22; 8:45 am] BILLING CODE 4163–18–P DEPARTMENT OF HEALTH AND HUMAN SERVICES Centers for Disease Control and Prevention [60Day–22–1291; Docket No. CDC–2022– 0097] Proposed Data Collection Submitted for Public Comment and Recommendations Centers for Disease Control and Prevention (CDC), Department of Health and Human Services (HHS). AGENCY: ACTION: Notice with comment period. The Centers for Disease Control and Prevention (CDC), as part of its continuing effort to reduce public burden and maximize the utility of government information, invites the general public and other federal agencies the opportunity to comment on a continuing information collection, as required by the Paperwork Reduction Act of 1995. This notice invites comment on a proposed information collection project titled Generic Information Collection Request for Cognitive Testing and Pilot Testing for the National Center for Chronic Disease Prevention and Health Promotion. The Generic Clearance is needed to support methodological studies that improve information quality and the efficiency of information collection. SUMMARY: lotter on DSK11XQN23PROD with NOTICES1 Number of responses per respondent Number of respondents Type of respondents CDC must receive written comments on or before October 25, 2022. DATES: VerDate Sep<11>2014 16:59 Aug 25, 2022 Jkt 256001 You may submit comments, identified by Docket No. CDC–2022– 0097 by either of the following methods: • Federal eRulemaking Portal: www.regulations.gov. Follow the instructions for submitting comments. • Mail: Jeffrey M. Zirger, Information Collection Review Office, Centers for Disease Control and Prevention, 1600 Clifton Road NE, MS H21–8, Atlanta, Georgia 30329. Instructions: All submissions received must include the agency name and Docket Number. CDC will post, without change, all relevant comments to www.regulations.gov. Please note: Submit all comments through the Federal eRulemaking portal (www.regulations.gov) or by U.S. mail to the address listed above. FOR FURTHER INFORMATION CONTACT: To request more information on the proposed project or to obtain a copy of the information collection plan and instruments, contact Jeffrey M. Zirger, Information Collection Review Office, Centers for Disease Control and Prevention, 1600 Clifton Road NE, MS H21–8, Atlanta, Georgia 30329; Telephone: 404–639–7118; Email: omb@ cdc.gov. SUPPLEMENTARY INFORMATION: Under the Paperwork Reduction Act of 1995 (PRA) (44 U.S.C. 3501–3520), federal agencies must obtain approval from the Office of Management and Budget (OMB) for each collection of information they conduct or sponsor. In addition, the PRA also requires federal agencies to provide a 60-day notice in the Federal Register concerning each proposed collection of information, including each new proposed collection, each proposed extension of existing collection of information, and each reinstatement of previously approved information collection before submitting the collection to the OMB for approval. To comply with this requirement, we are ADDRESSES: PO 00000 Frm 00078 Fmt 4703 Sfmt 4703 publishing this notice of a proposed data collection as described below. The OMB is particularly interested in comments that will help: 1. Evaluate whether the proposed collection of information is necessary for the proper performance of the functions of the agency, including whether the information will have practical utility; 2. Evaluate the accuracy of the agency’s estimate of the burden of the proposed collection of information, including the validity of the methodology and assumptions used; 3. Enhance the quality, utility, and clarity of the information to be collected; 4. Minimize the burden of the collection of information on those who are to respond, including through the use of appropriate automated, electronic, mechanical, or other technological collection techniques or other forms of information technology, e.g., permitting electronic submissions of responses; and 5. Assess information collection costs. Proposed Project Generic Information Collection Request (ICR) for Cognitive Testing and Pilot Testing for the National Center for Chronic Disease Prevention and Health Promotion (NCCDPHP) (OMB Control No. 0921–1291, Exp. 03/31/2023)— Extension—National Center for Chronic Disease Prevention and Health Promotion (NCCDPHP), Centers for Disease Control and Prevention (CDC). Background and Brief Description CDC’s National Center for Chronic Disease Prevention and Health Promotion (NCCDPHP) plans has established a Generic Clearance (OMB Control No. 0920–1291) to support information collection for cognitive testing and pilot testing activities. Information collections that support the E:\FR\FM\26AUN1.SGM 26AUN1

Agencies

[Federal Register Volume 87, Number 165 (Friday, August 26, 2022)]
[Notices]
[Pages 52575-52577]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2022-18443]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Centers for Disease Control and Prevention

[60Day-22-1166; Docket No. CDC-2022-0100]


Proposed Data Collection Submitted for Public Comment and 
Recommendations

AGENCY: Centers for Disease Control and Prevention (CDC), Department of 
Health and Human Services (HHS).

ACTION: Notice with comment period.

-----------------------------------------------------------------------

SUMMARY: The Centers for Disease Control and Prevention (CDC), as part 
of its continuing effort to reduce public burden and maximize the 
utility of government information, invites the general public and other 
federal agencies the opportunity to comment on a continuing information 
collection, as required by the Paperwork Reduction Act of 1995. This 
notice invites comment on a proposed information collection project 
titled Poison Center Collaborations for Public Health Emergencies. This 
proposed collection will allow CDC to quickly characterize potential 
exposures identified through the National Poison Data System (NPDS), 
help determine potential risk factors, identify illnesses related to 
the public health emergency, and improve the public health response to 
the incident.

[[Page 52576]]


DATES: CDC must receive written comments on or before October 25, 2022.

ADDRESSES: You may submit comments, identified by Docket No. CDC-2022-
0100 by either of the following methods:
     Federal eRulemaking Portal: www.regulations.gov. Follow 
the instructions for submitting comments.
     Mail: Jeffrey M. Zirger, Information Collection Review 
Office, Centers for Disease Control and Prevention, 1600 Clifton Road 
NE, MS H21-8, Atlanta, Georgia 30329.
    Instructions: All submissions received must include the agency name 
and Docket Number. CDC will post, without change, all relevant comments 
to www.regulations.gov.
    Please note: Submit all comments through the Federal eRulemaking 
portal (www.regulations.gov) or by U.S. mail to the address listed 
above.

FOR FURTHER INFORMATION CONTACT: To request more information on the 
proposed project or to obtain a copy of the information collection plan 
and instruments, contact Jeffrey M. Zirger, Information Collection 
Review Office, Centers for Disease Control and Prevention, 1600 Clifton 
Road NE, MS H21-8, Atlanta, Georgia 30329; Telephone: 404-639-7570; 
Email: [email protected].

SUPPLEMENTARY INFORMATION: Under the Paperwork Reduction Act of 1995 
(PRA) (44 U.S.C. 3501-3520), federal agencies must obtain approval from 
the Office of Management and Budget (OMB) for each collection of 
information they conduct or sponsor. In addition, the PRA also requires 
federal agencies to provide a 60-day notice in the Federal Register 
concerning each proposed collection of information, including each new 
proposed collection, each proposed extension of existing collection of 
information, and each reinstatement of previously approved information 
collection before submitting the collection to the OMB for approval. To 
comply with this requirement, we are publishing this notice of a 
proposed data collection as described below.
    The OMB is particularly interested in comments that will help:
    1. Evaluate whether the proposed collection of information is 
necessary for the proper performance of the functions of the agency, 
including whether the information will have practical utility;
    2. Evaluate the accuracy of the agency's estimate of the burden of 
the proposed collection of information, including the validity of the 
methodology and assumptions used;
    3. Enhance the quality, utility, and clarity of the information to 
be collected;
    4. Minimize the burden of the collection of information on those 
who are to respond, including through the use of appropriate automated, 
electronic, mechanical, or other technological collection techniques or 
other forms of information technology, e.g., permitting electronic 
submissions of responses; and
    5. Assess information collection costs.

Proposed Project

    Poison Center Collaborations for Public Health Emergencies (PCCPHE) 
(OMB Control No. 0920-1166, Exp. 04/30/2023)--Revision--National Center 
for Environmental Health (NCEH), Centers for Disease Control and 
Prevention (CDC).

Background and Brief Description

    The Centers for Disease Control and Prevention (CDC) is requesting 
a three-year Paperwork Reduction Act (PRA) Revision of the Generic 
Information Collection Request (Generic ICR) titled Poison Center 
Collaborations for Public Health Emergencies (PCCPHE) (OMB Control No. 
0920-1166; Expiration date 04/30/2023).
    CDC's key partner is America's Poison Centers \TM\, formerly known 
as the American Association of Poison Control Centers (AAPCC). 
America's Poison Centers \TM\ is a national network of 55 poison 
centers working to prevent and treat poison exposures. America's Poison 
Centers \TM\ manages its existing surveillance system called the 
National Poison Data System (NPDS) and provides CDC access to monitor 
this system under a cooperative agreement and a data license agreement.
    When a public health emergency of interest emerges in NPDS, the CDC 
and America's Poison Centers \TM\ hold a meeting to mutually decide 
whether the incident needs further investigation. For a public health 
emergency to be selected for call-back, adverse health effects must 
have occurred, and a response is needed to prevent further morbidity 
and mortality. The event must meet the following criteria: (1) the 
event is a public health emergency causing adverse health effects; (2) 
timely data are urgently needed to inform rapid public health action to 
prevent or reduce injury, disease, or death; (3) the event is 
characterized by a natural or man-made disaster, contaminated food or 
water, a new or existing consumer product, or an emerging public health 
threat; (4) the event has resulted in calls to a poison center, and the 
poison center agrees to conduct the call-back data collection; (5) the 
event is domestic; and (6) data collection will be completed in 60 days 
or less.
    The purpose of this Generic ICR is to create a timely mechanism to 
allow poison centers, supported by CDC, to follow-up with callers 
during select public health emergencies on exposure and health. These 
PCCPHE Generic information collections (GenICs) will obtain information 
on sources of exposure, scenario of exposure, health seeking behaviors 
following exposure, and awareness of health communication messaging. 
These additional data can help CDC identify interventions to improve 
health messaging meant to reduce exposure; improve disaster and 
emergency response; and prevent future events for the specific area or 
incident of interest.
    Trained poison center staff will conduct the call-back telephone 
survey or will facilitate the call-back web survey, after administering 
consent. Respondents will include individuals who call poison centers 
about exposures related to the select public health emergencies. These 
respondents include adults, 18 years and older; adolescents, 15 to less 
than 18 years; and parents or guardians on behalf of their children 
less than 15 years of age.
    In 2019, a PCCPHE GenIC, titled ``Risk Factors for Harmful Algal 
Blooms (HABs),'' was conducted to identify sources of and risk factors 
for HAB exposures. New information gained about HAB exposures were used 
improve HAB incident response, communication, and outreach at the state 
and national level.
    During the past three-year approval period, no PCCPHE GenICs were 
conducted; however, two NPDS-related follow-up studies were implemented 
using the Secretary's Public Health Emergency PRA Waiver for COVID-19. 
During a non-pandemic situation, these two studies would have used this 
Generic ICR. These studies assessed unintentional exposures associated 
with cleaning products (e.g., bleach, hand sanitizers) in home settings 
to determine knowledge, attitudes, and practices regarding cleaning 
behaviors and help guide public health messaging.
    Based on CDC's past experience, the following revisions affecting 
public burden are proposed. CDC plans to increase the annual number of 
public health emergencies of interest from two to three per year. CDC 
will reduce the estimated time per response from 40 minutes to 10 
minutes. CDC plans to add web surveys as a second secure mode of 
collection to the currently approved telephone surveys. CDC will also 
increase the annual number of

[[Page 52577]]

respondents from 150 to 500 per call-back investigation.
    Based on these revisions, the total number of annual respondents 
requested is 1,500, which is an increase of 1,200 over the 300 
respondents previously approved. The annual time burden requested is 
250 hours, which is an increase of 50 hours over the 200 hours 
previously approved. There is no cost to the respondents other than 
their time.

                                        Estimated Annualized Burden Hours
----------------------------------------------------------------------------------------------------------------
                                                                     Number of    Average burden
      Type of respondents           Form name        Number of     responses per   per response    Total burden
                                                    respondents     respondent      (in hours)      (in hours)
----------------------------------------------------------------------------------------------------------------
Adult Poison Center Callers...  Call-back                  1,200               1           10/60             200
                                 Questionnaire
                                 for Self.
Adolescent Poison Center        Call-back                    150               1           10/60              25
 Callers.                        Questionnaire
                                 for Self.
Parent or Guardian Poison       Call-back                    150               1           10/60              25
 Center Callers.                 Questionnaire
                                 for Proxy.
                                                 ---------------------------------------------------------------
    Total.....................  ................  ..............  ..............  ..............             250
----------------------------------------------------------------------------------------------------------------


Jeffrey M. Zirger,
Lead, Information Collection Review Office, Office of Scientific 
Integrity, Office of Science, Centers for Disease Control and 
Prevention.
[FR Doc. 2022-18443 Filed 8-25-22; 8:45 am]
BILLING CODE 4163-18-P


This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.